CCL2 and systemic lupus erythematosus: Consistent with above results in vitro, MBL treatment could suppress the pro-inflammatory cytokine TNF-α, MCP-1 and IL-6 while increase the expression of IL-10 in the renal macrophages (Figure 4A) and in serum of lupus mice (Figure 4B).